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Abstract
A recent paper in Drug and Alcohol Review analysed the information on cancer disseminated by 27 alcohol industry funded
organisations. The independent UK alcohol education charity Drinkaware was among the organisations whose information
was studied, and based on the analysis claims were made of misrepresentation of evidence about the alcohol-related risk of can-
cer and alcohol industry inﬂuence. This commentary challenges the validity of these ﬁndings in respect to the evidence relating
to the Drinkaware information, as the analysis is found to be misrepresenting the information by both disregarding the wider
information content provided and the order and prominence with which alcohol-related cancer risk is presented. Furthermore,
it is argued that the public has a right to be provided with relevant evidence-based information about cancer risk. It is critical
that Drinkaware’s important public health function is not compromised by unjustiﬁed allegations of inaccuracy and by unwar-
ranted attacks on its independence and integrity. [Larsen J, Wallace P, Sim F, Chick J, Jarvis S, Lidington I, Neidle S,
Ogden G, Owens L. Accuracy of alcohol and breast cancer risk information on Drinkaware’s website. Drug Alcohol
Rev 2018;37:304–306]
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As medical and scientiﬁc advisors to and responsible for
research within the independent UK alcohol education
charity Drinkaware, we write in response to the paper by
Professor Mark Petticrew et al. ‘How alcohol industry
organisations mislead the public about alcohol and cancer’
published online in Drug and Alcohol Review on
7 September 2017 [1]. This paper reports on a study
designed to analyse the information on cancer dissemi-
nated by alcohol industry funded organisations, most
commonly Social Aspects Public Relations Organisa-
tions. It reportedly aimed to determine the extent to
which the organisations selected for study fully and accu-
rately communicate the scientiﬁc evidence on cancer.
The authors report the ﬁndings of a qualitative
analysis of information related to alcohol and cancer
risk obtained from the websites and documents of
27 organisations. The analysis is reported to have
involved extraction of data independently by two
authors, who coded and analysed data using docu-
mentary analysis methods. They report their method
as comprising: ‘reading and understanding meanings
of individual texts to identify subthemes; identiﬁca-
tion of thematic clusters of nodes; triangulation
between documents and organisations; checking for
reliability/validity and the use of representative
examples.’
The authors claim that the analysis demonstrated
that most of the organisations included in the study
were disseminating misrepresentations of the evidence
about the association between alcohol and cancer, and
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that strategies of ‘denial/omission’, ‘distortion’ and
‘distraction’ were employed. The paper concluded that
the alcohol industry appears to be engaged in extensive
misrepresentation of evidence about the alcohol-
related risk of cancer through its inﬂuence on the orga-
nisations studied.
Drinkaware was included among the 27 organisa-
tions considered. We address in this commentary the
claims made in the paper speciﬁcally concerning Drin-
kaware, as we are only involved with information con-
tent provided by this organisation.
Looking at the substance of the analysis, material
from Drinkaware is explicitly mentioned in relation to
the ‘distraction’ strategy as an example of seeking to
minimise the role of alcohol by pointing to a wide
range of other risk factors, presenting alcohol as ‘just
one risk among many’. The one quote from the Drin-
kaware website that is presented in the manuscript is
the following:
‘For example, the fact that you are female is a risk factor
in developing breast cancer. We also know breast cancer is
age-related so you’re more likely to develop it as you get
older and that you’re more prone to breast cancer if it is
part of your family history. These are all factors beyond our
control. We also know that risk is related to the ‘hormone
environment’ that women experience during the course of
early pregnancy, child birth and breastfeeding which all
exert a protective effect.’
Petticrew et al. claim that providing this information
is misleading because it emphasises potential moderat-
ing factors ‘without acknowledging the clear indepen-
dent risk of alcohol consumption’. However, all the
statements made in this paragraph have long been
accepted as mainstream opinion in the breast cancer
medical and scientiﬁc community and there is over-
whelming evidence of their correctness. As medical and
scientiﬁc advisors we stand by the importance of
including this information, and it is our opinion that
without this paragraph we would have failed to provide
women with a complete picture of the risks of alcohol
and breast cancer, making us guilty of precisely the
crimes of omission of which Petticrew et al. accuse
other bodies.
Furthermore, in using only this quote the authors
fail to make any reference to the comprehensive provi-
sion of information in the preceding paragraphs on the
same Drinkaware webpage: ‘Alcohol and breast can-
cer’ (provided in Supplementary Table 2 published
together with the Petticrew et al. paper). This webpage
clearly, comprehensively and unequivocally sets out
the evidence linking alcohol to the causation of breast
cancer and its sources. The ﬁrst section on the web-
page presents the research evidence: ‘It is clear from a
number of large scale studies that there is a link
between alcohol consumption and cancer. Globally,
one in ﬁve (21.6%) of all alcohol-related deaths are
due to cancer. Breast cancer is the most common can-
cer among women’. Below this, three key points are
emphasised: ‘[t]here is good evidence to suggest that
alcohol increases the risk of developing breast cancer’;
‘[o]f course drinking alcohol does not mean you will
automatically get breast cancer, it does mean your risk
of developing it will be increased’ and ‘[h]ow much
you drink over your lifetime is what increases the risk’.
When presenting further details of the research evi-
dence it is highlighted that ‘[a] number of studies have
found that a woman’s risk of breast cancer increases by
7–12% for every 10 g of alcohol per day’. Throughout,
the relevant primary sources for these evidence claims
are clearly referenced. Other webpages on the Drinka-
ware website address the link between alcohol and sev-
eral other cancers, with which we note Petticrew et al.
do not ﬁnd fault.
Having reviewed very carefully the page singled out
for criticism by Petticrew et al., we stand by its content
and refute any misrepresentation of the clear indepen-
dent risk of alcohol consumption in relation to breast
cancer, either intentional or unintentional. Therefore,
such criticism is, in our considered opinion, wholly
unjustiﬁed and unprofessional.
Furthermore, we categorically refute the authors’
inference that information on alcohol and breast can-
cer provided by Drinkaware was inﬂuenced in any way
by the alcohol industry. Drinkaware was established in
2007 as an independent alcohol education charity. It is
run by an independent Board of Trustees, and all
medical and health information provided by Drink-
aware is developed with guidance from and approval of
an independent Medical Advisory Panel of senior
medical and scientiﬁc experts. Drinkaware is acknowl-
edged by UK government agencies to be a major pro-
vider of evidence-based public information on alcohol
in the UK, with more than 9 million individual website
visitors each year [2] and in excess of 400,000 people
have downloaded the Drinkaware ‘Track and Calcu-
late Units’ app [3].
It is vital that Drinkaware’s important public health
function is not compromised by unjustiﬁed allega-
tions of inaccuracy and by entirely unwarranted
attacks on its independence and integrity. We there-
fore expect Petticrew et al. to address the inaccura-
cies in their paper, which we have highlighted in this
commentary.
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